Medtronic’s Trial for Extended-Wear Infusion Set Gets Go-Ahead
A pivotal trial for Medtronic’s extended-wear infusion set has received the FDA’s blessing.
The study aims to collect clinical data to support the use of the infusion set for up to one week, more than double the length of time that infusions set can currently be used.
Infusion sets are used for patients on insulin pump therapy to deliver insulin beneath the skin and maintain blood glucose levels. Currently, infusion sets must be switched out every two to three days, Medtronic said.